Regulus Therapeutics Inc. sell StockNews.com
Start price
10.05.25
/
50%
€7.25
Target price
10.05.26
-
Performance (%)
-2.76%
Price
07.07.25
€7.05
Summary
This prediction is currently active. With a performance of -2.76%, the SELL prediction for Regulus Therapeutics Inc. by StockNews_com is down slightly. This prediction currently runs until 10.05.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regulus Therapeutics Inc. | - | - |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by StockNews_com for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for RGLS provided by MarketBeat
Stopped prediction by StockNews_com for Regulus Therapeutics Inc.
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€7.00
18.05.25
18.05.25
-
18.05.26
18.05.26
0.00%
07.07.25
07.07.25
